BR112012030652A2 - comprimidos que podem ser dispersos oralmente de eritritol e isomalte - Google Patents

comprimidos que podem ser dispersos oralmente de eritritol e isomalte

Info

Publication number
BR112012030652A2
BR112012030652A2 BR112012030652A BR112012030652A BR112012030652A2 BR 112012030652 A2 BR112012030652 A2 BR 112012030652A2 BR 112012030652 A BR112012030652 A BR 112012030652A BR 112012030652 A BR112012030652 A BR 112012030652A BR 112012030652 A2 BR112012030652 A2 BR 112012030652A2
Authority
BR
Brazil
Prior art keywords
tablets
seconds
isomalt
erythritol
orally
Prior art date
Application number
BR112012030652A
Other languages
English (en)
Portuguese (pt)
Inventor
Catherine Patricia L Boghmans
Liesbeth Maria Fernande Meeus
Original Assignee
Cargill Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cargill Inc filed Critical Cargill Inc
Publication of BR112012030652A2 publication Critical patent/BR112012030652A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BR112012030652A 2010-06-01 2011-05-17 comprimidos que podem ser dispersos oralmente de eritritol e isomalte BR112012030652A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10005677 2010-06-01
PCT/EP2011/002432 WO2011151018A2 (en) 2010-06-01 2011-05-17 Orodispersible tablets of erythritol and isomalt

Publications (1)

Publication Number Publication Date
BR112012030652A2 true BR112012030652A2 (pt) 2016-08-16

Family

ID=42735711

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012030652A BR112012030652A2 (pt) 2010-06-01 2011-05-17 comprimidos que podem ser dispersos oralmente de eritritol e isomalte

Country Status (9)

Country Link
US (1) US20130072578A1 (cg-RX-API-DMAC7.html)
EP (1) EP2575755A2 (cg-RX-API-DMAC7.html)
JP (1) JP5902677B2 (cg-RX-API-DMAC7.html)
KR (1) KR20130086159A (cg-RX-API-DMAC7.html)
CN (1) CN102905691A (cg-RX-API-DMAC7.html)
BR (1) BR112012030652A2 (cg-RX-API-DMAC7.html)
CA (1) CA2800266A1 (cg-RX-API-DMAC7.html)
MX (1) MX2012013759A (cg-RX-API-DMAC7.html)
WO (1) WO2011151018A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6012373B2 (ja) * 2012-09-28 2016-10-25 杏林製薬株式会社 口腔内崩壊錠
JP7486258B2 (ja) * 2019-12-26 2024-05-17 物産フードサイエンス株式会社 口腔内崩壊錠用顆粒、その製造方法および口腔内崩壊錠
CN112137097A (zh) * 2020-10-10 2020-12-29 广东青云山药业有限公司 一种口腔速溶颗粒及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2189227C2 (ru) * 1996-07-12 2002-09-20 Дайити Фармасьютикал Ко., Лтд. Быстро распадающиеся прессованные в формах материалы и способ их получения
JPH10182436A (ja) * 1996-10-31 1998-07-07 Takeda Chem Ind Ltd 固形医薬製剤
EP1773292B1 (en) * 2004-07-01 2009-03-11 LEK Pharmaceuticals D.D. Rapidly disintegrating orodispersible composition containing nonfilamentous coprocessed polyols particles and silicified microcrystalline cellulose
JP2008037853A (ja) * 2006-08-01 2008-02-21 Higuchi Shokai:Kk イソマルトを含有する速崩壊性医薬品固形製剤
WO2009016133A1 (en) 2007-07-27 2009-02-05 Cargill, Incorporated Micronization of polyols
EP2153822A1 (en) * 2008-08-13 2010-02-17 Lek Pharmaceuticals D.D. Granulation of active pharmaceutical ingredients
FR2933299B1 (fr) 2008-07-04 2012-02-03 Roquette Freres Mannitol orodispersible
ES2377869T3 (es) 2008-09-04 2012-04-02 Cargill, Incorporated Fabricación de comprimidos de eritritol
US9101565B2 (en) 2008-11-17 2015-08-11 Takeda Nycomed As Dissolution stability of calcium carbonate tablets

Also Published As

Publication number Publication date
CN102905691A (zh) 2013-01-30
MX2012013759A (es) 2013-01-24
WO2011151018A2 (en) 2011-12-08
US20130072578A1 (en) 2013-03-21
KR20130086159A (ko) 2013-07-31
EP2575755A2 (en) 2013-04-10
CA2800266A1 (en) 2011-12-08
JP5902677B2 (ja) 2016-04-13
WO2011151018A3 (en) 2012-05-31
JP2013530163A (ja) 2013-07-25

Similar Documents

Publication Publication Date Title
Late et al. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets
Zhu et al. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats
BR112014018378A8 (pt) Processo contínuo para a preparação de um comprimido compreendendo ácido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol5-il) ciclopropanocarboxamido)-3-metilpiridin-2-il)benzoico
ES2812198T1 (es) Formulación de disolución rápida de un compuesto activo-receptor de calcio
BRPI0606332A2 (pt) composição farmacêutica de bendamustina, preparação liofilizada, forma de dosagem farmacêutica, método para obter aprovação oficial para um produto de bendamustina, processo para fabricar uma preparação liofilizada de bendamustina, solução ou dispersão de pré-liofilização de bendamustina, pó liofilizado, método para preparar uma preparação liofilizada de bendamustina, formulação para liofilização, e, uso de uma solução farmaceuticamente aceitável
BRPI0707044B8 (pt) comprimido matricial insolúvel em água e processo de fabricação de comprimidos matriciais
Pathan et al. Formulation design and optimization of novel mouth dissolving tablets for venlafaxine hydrochloride using sublimation technique
AR065096A1 (es) Preparacion solida
FI3182975T3 (fi) Rukaparibin suuren annosvahvuuden tabletteja
UA116334C2 (uk) Тверді форми дозування бендамустину
AR077546A1 (es) Formulaciones de comprimidos de 3-cianoquinolina y usos de los mismos
AR107391A1 (es) Formulaciones / composiciones que comprenden un inhibidor de btk
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
NO20090980L (no) Kapecitabin pediatriske tabeletter
AR100977A1 (es) Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación
JP2016108327A5 (cg-RX-API-DMAC7.html)
AR061790A1 (es) Composicion farmaceutica solida para la administracion oral, formulaciones de comprimidos de liberacion inmediata de un antagonista del receptor de trombina, y su uso en la manufactura de un medicamento
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
BR112013022017A2 (pt) formulação farmacêutica, comprimido, e, método para produzir uma formulação farmacêutica
CN101632644B (zh) 厄贝沙坦分散片及其制备方法
ECSP16005208A (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
AR080895A1 (es) Formulacion de comprimido de ezatiostat
PE20160245A1 (es) Composicion farmaceutica anti-tuberculosis estable en una forma de un comprimido dispersable que comprende granulos de isoniazid y granulos de rifapentina y su proceso de preparacion
WO2011151018A3 (en) Orodispersible tablets of erythritol and isomalt
Tabbakhian et al. Formulation and evaluation of orally disintegrating tablet of Rizatriptan using natural superdisintegrant

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]